Argent Biopharma ( (AU:RGT) ) just unveiled an update.
Argent Biopharma Limited announced the issuance of 2,500,000 ordinary fully paid shares, which were approved at the company’s general meeting on April 11, 2025. This move is part of the company’s strategy to enhance its market presence and operational capabilities, potentially impacting its industry positioning and offering new opportunities for stakeholders.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange (ASX) under the issuer code RGT.
YTD Price Performance: -20.83%
Average Trading Volume: 554
Technical Sentiment Signal: Buy
Current Market Cap: $6.65M
See more insights into RGT stock on TipRanks’ Stock Analysis page.